|
SOCS6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.023900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.103870E-02 |
| Normal-vs-Stage2 |
7.352200E-01 |
| Normal-vs-Stage3 |
3.602100E-02 |
| Normal-vs-Stage4 |
5.896300E-03 |
| Stage1-vs-Stage2 |
8.276100E-02 |
| Stage1-vs-Stage3 |
6.216000E-01 |
| Stage1-vs-Stage4 |
3.933000E-01 |
| Stage2-vs-Stage3 |
6.435800E-02 |
| Stage2-vs-Stage4 |
4.482200E-02 |
| Stage3-vs-Stage4 |
6.047600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.799900E-02 |
| Normal-vs-AfricanAmerican |
1.558040E-01 |
| Normal-vs-Asian |
1.140050E-02 |
| Caucasian-vs-AfricanAmerican |
8.639000E-01 |
| Caucasian-vs-Asian |
3.398600E-01 |
| AfricanAmerican-vs-Asian |
2.867600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.421630E-02 |
| Normal-vs-Female |
8.731200E-01 |
| Male-vs-Female |
5.990100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.835400E-01 |
| Normal-vs-Extreme_Weight |
3.164500E-03 |
| Normal-vs-Obese |
1.792770E-01 |
| Normal-vs-Extreme_Obese |
1.281370E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.374800E-01 |
| Normal_Weight-vs-Obese |
9.163600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.713400E-01 |
| Extreme_Weight-vs-Obese |
1.452420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.398200E-01 |
| Obese-vs-Extreme_Obese |
4.025200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.138800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.041400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.959500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.593610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.810800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.044400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.650600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.589960E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.692400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.114400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.738400E-02 |
| Normal-VS-Type2 PRCC |
2.639700E-02 |
| Normal-VS-KIRP CIMP |
9.578300E-03 |
| Normal-VS-Unclassified PRCC |
5.869400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.312400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.199570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.028000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.650600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.045210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.659700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.942200E-02 |
| Normal-vs-N1 |
1.073440E-01 |
| Normal-vs-N2 |
1.179440E-03 |
| N0-vs-N1 |
8.423800E-01 |
| N0-vs-N2 |
2.396000E-01 |
| N1-vs-N2 |
2.220000E-01 |
|
|
